The method assesses growth rates of the tumour and detects gene patterns that can forecast outcomes of the patient.

Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma (MM) and its precursor conditions. The new method, known as SWIFT-seq, ...

Using flow cytometry, we noted a significant increase in M1 macrophage markers following the addition of exosome inhibitors, indicating that exosomes might play a role in M1 macrophage polarization.